Supplementary Figure 1 from Single-Domain Antibody–Based and Linker-Free Bispecific Antibodies Targeting FcγRIII Induce Potent Antitumor Activity without Recruiting Regulatory T Cells
crossref(2023)
摘要
PDF file - 60K, Lack of competition between bsFab and human IgG for FcγRIIIa binding.
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要